Send to:

Choose Destination
See comment in PubMed Commons below
J Biopharm Stat. 2011 Sep;21(5):971-91. doi: 10.1080/10543406.2011.590922.

Joint modeling of multiple longitudinal patient-reported outcomes and survival.

Author information

  • 1Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.


Researchers often include patient-reported outcomes (PROs) in Phase III clinical trials to demonstrate the value of treatment from the patient's perspective. These data are collected as longitudinal repeated measures and are often censored by occurrence of a clinical event that defines a survival time. Hierarchical Bayesian models having latent individual-level trajectories provide a flexible approach to modeling such multiple outcome types simultaneously. We consider the case of many zeros in the longitudinal data motivating a mixture model, and demonstrate several approaches to modeling multiple longitudinal PROs with survival in a cancer clinical trial. These joint models may enhance Phase III analyses and better inform health care decision makers.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk